



LDLR Antibody (B-10) is a mouse monoclonal IgG2b antibody that detects low density lipoprotein receptor (LDLR) in human samples through applications such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA). Anti-LDLR antibody (B-10) plays a crucial role in understanding the function of LDLR, which is essential for mediating the uptake of low density lipoprotein (LDL) and its subsequent degradation in lysosomes, thereby providing cholesterol to cells. This process is vital for maintaining cellular cholesterol homeostasis and overall lipid metabolism. LDLR (B-10) antibody enables researchers to study the LDL receptor located on the cell surface as a transmembrane protein, where the cytoplasmic domain is critical for clustering in coated pits, facilitating rapid endocytosis of bound LDL. Dysregulation or mutations in the LDLR gene can lead to familial hypercholesterolemia, a genetic disorder characterized by elevated cholesterol levels and an increased risk of premature coronary atherosclerosis. LDLR monoclonal antibody (B-10) helps researchers gain insights into the mechanisms of cholesterol uptake and the implications of LDLR dysfunction in cardiovascular diseases.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
LDLR Antibody (B-10) | sc-373831 | 200 µg/ml | $322.00 | |||
LDLR Antibody (B-10): m-IgGκ BP-HRP Bundle | sc-535317 | 200 µg Ab; 40 µg BP | $361.00 | |||
LDLR Antibody (B-10): m-IgG2b BP-HRP Bundle | sc-549392 | 200 µg Ab; 10 µg BP | $361.00 |